Dear Members,

As an endorsing society of the World Congress on Interventional Therapies for Type 2 Diabetes (WCITD 2019), held in partnership with the American Diabetes Association (ADA), we would like to share with you two important updates and benefits that you are entitled to.

  • The early bird registration deadline has been extended until January 22, 2019 – save up to $230. Simply indicate that you are a member on the online registration form. Register today
  • Late-breaking abstract submission is now open until January 30, 2019. Accepted abstracts will be eligible for consideration for submission in manuscript form for peer review and possible publication in a special issue of Diabetes Care, the flagship journal of the American Diabetes Association (ADA). Use this opportunity and submit your abstract.


WCITD 2019 will convene clinicians, scientists, and policy makers to discuss the latest findings on metabolic/bariatric surgery and novel interventional therapies for type 2 diabetes. The Organizing Committee is led by Francesco Rubino (Congress Director), together with Philip Schauer, David Cummings, Lee Kaplan, and William Cefalu (Program Co-Chairs). The first three editions were attended by participants from over 60 countries, including world leading experts and Nobel Prize Laureates. The upcoming congress will build on the success of previous events, with a focus on providing access to cutting-edge treatment and moving forward “From Guidelines to Implementation”.


Find more information on the congress website: www.wcitd.com

See you April 8-10 in New York!

 
 
 

Follow #WCITD19 on social media:



CONTACT US